当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析 - 现金流量表

南微医学

(688029)

  

流通市值:159.71亿  总市值:159.71亿
流通股本:1.88亿   总股本:1.88亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金844,007,963.33,334,176,666.22,496,182,491.911,670,186,983.86
  收到的税费返还4,236,766.3112,255,560.139,697,086.119,275,495.94
  收到其他与经营活动有关的现金13,155,065.176,514,804.6560,553,645.237,317,413.33
  经营活动现金流入小计861,399,794.713,422,947,030.982,566,433,223.221,716,779,893.13
  购买商品、接受劳务支付的现金350,387,852.431,201,136,680.78897,431,648.8633,004,829.96
  支付给职工以及为职工支付的现金282,280,371.85795,544,556.02645,237,236.2451,599,293.4
  支付的各项税费36,985,662.63212,145,329.7162,546,731.197,204,782.03
  支付其他与经营活动有关的现金85,343,129.1526,174,710.85383,689,106.66232,788,536.02
  经营活动现金流出小计754,997,016.012,735,001,277.352,088,904,722.761,414,597,441.41
  经营活动产生的现金流量净额106,402,778.7687,945,753.63477,528,500.46302,182,451.72
二、投资活动产生的现金流量:
  收回投资收到的现金2,474,981,569.981,527,310,151.52861,470,111.64463,428,578.54
  取得投资收益收到的现金7,453,797.3434,625,622.1924,923,086.622,241,842.98
  处置固定资产、无形资产和其他长期资产收回的现金净额692.843,702,004.03153,627153,627
  收到的其他与投资活动有关的现金-60,592,477.753,869,20053,869,200
  投资活动现金流入小计2,482,436,060.161,626,230,255.44940,416,025.24539,693,248.52
  购建固定资产、无形资产和其他长期资产支付的现金107,452,938.68254,930,231.13210,279,742.27180,536,086.41
  投资支付的现金2,756,282,760.812,056,029,942.17591,976,885.59128,841,574.05
  取得子公司及其他营业单位支付的现金-240,280,432.95240,301,599.84240,301,599.84
  投资活动现金流出小计2,863,735,699.492,551,240,606.251,042,558,227.7549,679,260.3
  投资活动产生的现金流量净额-381,299,639.33-925,010,350.81-102,142,202.46-9,986,011.78
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,027,781.88,000,002.88,000,002.87,785,602.8
  其中:子公司吸收少数股东投资收到的现金5,027,781.88,000,002.88,000,002.87,785,602.8
  取得借款收到的现金-190,000,000190,000,00065,000,000
  筹资活动现金流入小计5,027,781.8198,000,002.8198,000,002.872,785,602.8
  偿还债务支付的现金191,227,752.0673,517,413.7786,490,690.9186,830,966.1
  分配股利、利润或偿付利息支付的现金229,534.72282,297,811.94280,480,889.05186,871,269.94
  支付其他与筹资活动有关的现金3,393,912.4446,012,992.2521,026,107.578,636,539.6
  筹资活动现金流出小计194,851,199.22401,828,217.96387,997,687.53282,338,775.64
  筹资活动产生的现金流量净额-189,823,417.42-203,828,215.16-189,997,684.73-209,553,172.84
四、汇率变动对现金及现金等价物的影响-41,618,903.547,352,730.8930,364,694.2857,358,248.08
五、现金及现金等价物净增加额-506,339,181.59-433,540,081.45215,753,307.55140,001,515.18
  加:期初现金及现金等价物余额1,436,676,056.751,870,216,138.21,870,216,138.21,870,216,138.2
  期末现金及现金等价物余额930,336,875.161,436,676,056.752,085,969,445.752,010,217,653.38
补充资料:
  净利润-582,557,650.02-379,758,886.04
  资产减值准备-42,513,477.38-9,266,509.45
  固定资产和投资性房地产折旧-68,835,313.4-35,139,816.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-68,835,313.4-35,139,816.17
  无形资产摊销-36,595,161.58-15,295,810.76
  长期待摊费用摊销-19,867,459.75-9,293,890.52
  处置固定资产、无形资产和其他长期资产的损失--103,715.12-7,425.13
  固定资产报废损失-444,186.47-174,424.23
  公允价值变动损失--928,013.63--403,050.42
  财务费用--18,591,035.1--55,312,344.2
  投资损失--16,942,047.43--6,222,947.56
  递延所得税--7,964,000.27--3,151,689.04
  其中:递延所得税资产减少--6,966,876.09--3,282,458.73
    递延所得税负债增加--997,124.18-130,769.69
  存货的减少--54,279,029.92--70,312,856.24
  经营性应收项目的减少-16,354,183.31--29,364,464.86
  经营性应付项目的增加--10,562,073.84-5,597,792.35
  其他---2,763,888.9
  现金的期末余额-1,436,676,056.75-2,010,217,653.38
  减:现金的期初余额-1,870,216,138.2-1,870,216,138.2
  现金及现金等价物的净增加额--433,540,081.45-140,001,515.18
公告日期2026-04-282026-04-282025-10-282025-08-12
审计意见(境内)标准无保留意见
TOP↑